Here, we demonstrated a novel mechanism by which partially hydrolysed whey formula and its hydrolysate can reduce TEWL, modulate barrier-related gene expression notably AQP3 gene, and thus possibly improve skin barrier function in an Af model. This evidence concerns the gene AQP3 and atrial fibrillation.